Clinical Trial Update: Eplerenone in Systemic Right Ventricle [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating eplerenone in patients with a systemic right ventricle after an atrial switch for transposition of the great arteries has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transposition of the Great Arteries

Drugs mentioned

• Inspra (eplerenone)

Snippet

Sponsor: Hospital Universitari Vall d'Hebron Research Institute | Conditions: Transposition of Great Vessels, Atrial Switch Procedure | Phase 4 | Status: COMPLETED